FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

25 results

advair
(fluticasone propionate and salmeterol)
GlaxoSmithKline LLC
Usage: ADVAIR DISKUS is indicated for the twice-daily treatment of asthma in patients aged 4 and older and for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for acute bronchospasm relief or for patients not adequately controlled on long-term asthma medications.
albuterol sulfate
(Albuterol Sulfate)
Sandoz Inc
Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 years and older with reversible obstructive airway disease and for preventing exercise-induced bronchospasm.
albuterol sulfate
(Albuterol Sulfate)
Ritedose Pharmaceuticals, LLC
Usage: Albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and for managing acute bronchospasm attacks.
albuterol sulfate
(Albuterol Sulfate)
Nephron Pharmaceuticals Corporation
Usage: Albuterol inhalation solution is indicated for the relief of bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and during acute bronchospasm attacks.
albuterol sulfate
(Albuterol Sulfate)
Armstrong Pharmaceuticals, Inc.
Usage: Albuterol Sulfate Inhalation Aerosol is indicated for treating or preventing bronchospasm in patients aged 4 and older with reversible obstructive airway disease, as well as for preventing exercise-induced bronchospasm in the same age group.
albuterol sulfate inhalation solution
(Albuterol Sulfate)
Ritedose Pharmaceuticals, LLC
Usage: Albuterol Sulfate Inhalation Solution is indicated for relieving bronchospasm in patients aged 2 to 12 years with asthma (reversible obstructive airway disease).
albuterol sulfate inhalation solution, 0.5%
(Albuterol Sulfate)
Ritedose Pharmaceuticals, LLC
Usage: Albuterol sulfate inhalation solution is indicated for relieving bronchospasm in patients aged 12 and older with reversible obstructive airway disease and during acute bronchospasm attacks.
anoro ellipta
(umeclidinium bromide and vilanterol trifenatate)
GlaxoSmithKline LLC
Usage: ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.
arformoterol tartrate
(Arformoterol tartrate)
Alembic Pharmaceuticals Inc.
Usage: Arformoterol tartrate inhalation solution is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, via nebulization. It is not intended for acute COPD exacerbations or for treating asthma.
arformoterol tartrate
(arformoterol tartrate)
Lifestar Pharma LLC
Usage: Arformoterol tartrate inhalation solution is indicated for the long-term, twice daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is not intended for acute COPD exacerbations or for the treatment of asthma.

beta2-Adrenergic Agonist class drugs

advair

albuterol sulfate

albuterol sulfate

albuterol sulfate

albuterol sulfate

albuterol sulfate inhalation solution

albuterol sulfate inhalation solution, 0.5%

anoro ellipta

arformoterol tartrate

arformoterol tartrate